4559:TYO
Zeria Pharmaceutical Co Ltd
¥1,903.00
arrow_upward
+0.26%(+5.00) 1D
Oct 5, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥1,901
High
¥1,908
Low
¥1,895
Mkt. cap
95.38B
Avg. vol.
167.72K
Volume
125.40K
Dividend
2.57%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.19
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
Open
¥1,901
High
¥1,908
Low
¥1,895
Mkt. cap
95.38B
Avg. vol.
167.72K
Volume
125.40K
Dividend
2.57%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.19
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
www.marketscreener.com
·
1 hour ago
Kura Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Investing News Network
·
1 hour ago
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
Benzinga
·
59 minutes ago
Greenland Mines (NASDAQ: GRML) Completes 2026 Skaergaard Field Program
Yahoo Finance
·
1 hour ago
Prediction: This Lesser-Known Growth ETF Will Crush the S&P 500 Over the Next 20 Years
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp